Kc Investment Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Kc Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $158,200 - $234,359	-775 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $7,665 - $10,863	30 Added 4.03%	775 $220,000
Q4 2021 Feb 15, 2022	BUY	$351.38 - $448.68 $4,919 - $6,281	14 Added 1.92%	745 $281,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $3,726 - $4,583	10 Added 1.39%	731 $302,000
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $5,589 - $7,061	19 Added 2.71%	721 $267,000
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $175,268 - $210,234	702 New	702 $203,000

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Kc Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kc Investment Advisors, LLC with notifications on news.